Ignite Creation Date:
2025-12-25 @ 2:35 AM
Ignite Modification Date:
2025-12-26 @ 1:12 AM
Study NCT ID:
NCT04857034
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-10
First Post:
2021-04-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-12
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2028-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-20
First Submit QC Date:
None
Study First Post Date:
2021-04-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-08-21
Results First Submit QC Date:
None
Results First Post Date:
2025-09-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-21
Last Update Post Date:
2025-09-10
Last Update Post Date Type:
ESTIMATED